
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.70 | 0.70 | 0.00 |
Shares | 99.30 | 99.30 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.87 | 23.11 |
Price to Book | 8.04 | 4.57 |
Price to Sales | 5.10 | 3.48 |
Price to Cash Flow | 18.65 | 15.76 |
Dividend Yield | 1.66 | 1.29 |
5 Years Earnings Growth | 9.22 | 11.46 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 25.91 | 14.59 |
Consumer Defensive | 22.37 | 6.14 |
Technology | 20.89 | 27.67 |
Communication Services | 13.90 | 8.91 |
Consumer Cyclical | 9.35 | 12.50 |
Financial Services | 4.87 | 14.95 |
Industrials | 2.71 | 12.30 |
Number of long holdings: 27
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 9.40 | 635.38 | -0.27% | |
Microsoft | US5949181045 | 8.94 | 452.38 | -1.26% | |
Novo Nordisk B | DK0062498333 | 6.50 | 456.6 | +0.11% | |
Stryker | US8636671013 | 6.46 | 379.75 | -2.52% | |
L'Oreal | FR0000120321 | 5.12 | 385.45 | +1.15% | |
ADP | US0530151036 | 4.84 | 322.63 | -0.05% | |
Visa A | US92826C8394 | 4.83 | 358.30 | -2.33% | |
Philip Morris | US7181721090 | 4.67 | 174.63 | +0.29% | |
Waters | US9418481035 | 4.45 | 347.36 | -4.07% | |
Alphabet A | US02079K3059 | 4.40 | 168.56 | +2.79% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity R Acc | 548.86M | -7.55 | 2.66 | 11.51 | ||
Fundsmith Equity T Acc | 3.66B | -7.40 | 3.17 | 12.07 | ||
Fundsmith Equity T Inc | 219.22M | -7.51 | 3.17 | 12.07 | ||
Fundsmith Equity I Acc | 12.59B | -7.37 | 3.27 | 12.19 | ||
Fundsmith Equity I Inc | 3.69B | -7.54 | 3.27 | 12.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review